Tilray Brands (TLRY) Amortization - Intangibles (2021 - 2026)
Tilray Brands (TLRY) posted Amortization - Intangibles of $5.1 million for Q1 2026, up 17.16% on a QoQ basis from $4.4 million in Q4 2025, and down 77.97% year-over-year from $23.2 million in Q1 2025.
Tilray Brands (TLRY) Amortization - Intangibles (2021 - 2026) Analysis & Trends
Tilray Brands' Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- Quarterly Amortization - Intangibles fell 77.97% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $34.1 million (down 60.79% YoY) and the FY2025 annual result came in at $88.6 million, up 4.56% from the prior year.
- Amortization - Intangibles was $5.1 million for Q1 2026 at Tilray Brands, up from $4.4 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $30.8 million in Q2 2022 and bottomed at $3.9 million in Q3 2025.
- A 5-year average of $19.7 million and a median of $21.9 million in 2023 frame the typical range for Amortization - Intangibles.
- Peak annual rise in Amortization - Intangibles reached 8.67% in 2025, while the deepest fall reached 81.98% in 2025.
- Tilray Brands' Amortization - Intangibles stood at $24.0 million in 2022, then retreated by 8.66% to $21.9 million in 2023, then rose by 4.61% to $22.9 million in 2024, then sank by 80.99% to $4.4 million in 2025, then gained by 17.16% to $5.1 million in 2026.
- Business Quant data shows TLRY's Amortization - Intangibles at $5.1 million in Q1 2026, $4.4 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Tilray Brands | 439.44 Mn | 379.24 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 5.11 Mn |
| Nov 30, 2025 | 4.36 Mn |
| Aug 31, 2025 | 3.93 Mn |
| May 31, 2025 | 20.70 Mn |
| Feb 28, 2025 | 23.18 Mn |
| Nov 30, 2024 | 22.93 Mn |
| Aug 31, 2024 | 21.80 Mn |
| May 31, 2024 | 19.05 Mn |
| Feb 29, 2024 | 21.56 Mn |
| Nov 30, 2023 | 21.92 Mn |
| Aug 31, 2023 | 22.23 Mn |
| May 31, 2023 | 21.62 Mn |
| Feb 28, 2023 | 23.52 Mn |
| Nov 30, 2022 | 24.00 Mn |
| Aug 31, 2022 | 24.36 Mn |
| May 31, 2022 | 30.85 Mn |
| Feb 28, 2022 | 24.59 Mn |
| Nov 30, 2021 | 29.02 Mn |